<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:hpo ids='HP_0100512'>Vitamin D deficiency</z:hpo> may increase the risk for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>African Americans tend to have poor <z:chebi fb="27" ids="27300">vitamin D</z:chebi> status and increased risk of <z:mp ids='MP_0002055'>diabetes</z:mp>, but effects of <z:chebi fb="27" ids="27300">vitamin D</z:chebi> supplementation on components of <z:mp ids='MP_0002055'>diabetes</z:mp> risk have not been tested in this group </plain></SENT>
<SENT sid="2" pm="."><plain>This study was conducted to determine whether <z:chebi fb="27" ids="27300">vitamin D</z:chebi> supplementation improves insulin secretion, insulin sensitivity and glycaemia in African Americans with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> or early <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In this randomized, placebo-controlled trial, we examined the effect of 4000 IU/day <z:chebi fb="27" ids="27300">vitamin D</z:chebi>(3,) on glycaemia and contributing measures including insulin secretion, insulin sensitivity and the disposition index over 12 weeks in 89 overweight or <z:mp ids='MP_0001261'>obese</z:mp> African Americans with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> or early <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Outcome measures were derived from oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance testing </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Mean plasma 25-hydroxyvitamin D was about 40 nmol/l in the placebo and <z:chebi fb="27" ids="27300">vitamin D</z:chebi> groups at baseline and increased to 81 nmol/l with supplementation </plain></SENT>
<SENT sid="6" pm="."><plain>Insulin sensitivity decreased by 4% in the <z:chebi fb="27" ids="27300">vitamin D</z:chebi> group compared with a 12% increase in the placebo group (p = 0.034) </plain></SENT>
<SENT sid="7" pm="."><plain>Insulin secretion increased by 12% in the <z:chebi fb="27" ids="27300">vitamin D</z:chebi> group compared with a 2% increase in the placebo group (p = 0.024), but changes in the disposition index were similar across groups </plain></SENT>
<SENT sid="8" pm="."><plain>There was no effect of supplementation on post-load <z:chebi fb="105" ids="17234">glucose</z:chebi> or other measures of glycaemia </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Supplementation with 4000 IU/day <z:chebi fb="27" ids="27300">vitamin D</z:chebi>(3) successfully corrected <z:chebi fb="27" ids="27300">vitamin D</z:chebi> insufficiency and had divergent effects on insulin secretion and sensitivity with no overall effect on disposition index or glycaemia </plain></SENT>
<SENT sid="10" pm="."><plain>In this study, <z:chebi fb="27" ids="27300">vitamin D</z:chebi> supplementation for 3 months did not change the pathophysiology of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> in overweight and <z:mp ids='MP_0001261'>obese</z:mp> African Americans </plain></SENT>
</text></document>